Becton, Dickinson and Company (BDX) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI

Becton, Dickinson and Company (BDX) Fundamentals — Income, Balance Sheet & Cash Flow | MarketCI | MarketCI

BDX

Market Closed

Becton, Dickinson and Company

NYSEHealthcare Medical - Instruments & Supplies

70.00K employees

CEO: Thomas E. Polen Jr.

Founded: 1973

$143.98

+$0.00(+NaN%)

Market Cap

52.16B

Beta

0.28

52W Range

N/A

Dividend Yield

2.60%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

Financial Statements

Comprehensive breakdown of financial statements and performance metrics

Gross Margin

45.4%

8.8%

CAGR: 3.6%

Profit after direct costs

Operating Margin

11.8%

7.6%

CAGR: 3.5%

Core business profitability

Net Margin

7.7%

-1.6%

CAGR: -5.4%

Bottom line profitability

Revenue Growth

8.2%

YoY

CAGR: 3.4%

Top line growth rate

Revenue Flow Analysis

Visual flow showing how BDX allocates revenue across expenses and profit

Fiscal Year 2025

Revenue Distribution

Flow of revenue through cost categories to net income

Gross Margin

45.4%

$9.92B

Operating Margin

11.8%

$2.58B

Net Margin

7.7%

$1.68B

Detailed Income Statement

Complete profit and loss breakdown with margin analysis and historical comparison

Item	2021	2022	2023	2024	2025	YoY Change
Total Revenue	19.13B	18.87B	19.37B	20.18B	21.84B	8.2%
Cost of Revenue	(10.50B)	(10.39B)	(11.20B)	(11.05B)	(11.91B)	7.8%
Gross Profit	8.63B	8.48B	8.17B	9.13B	9.92B	8.8%
Operating Expenses
Research & Development	(1.28B)	(1.26B)	(1.24B)	(1.19B)	(1.26B)	6.2%
Selling, General & Administrative	(4.72B)	(4.71B)	(4.72B)	(4.86B)	(5.28B)	8.6%
Depreciation & Amortization	(2.23B)	(2.23B)	(2.29B)	(2.29B)	(2.46B)	7.7%
Operating Income (EBIT)	2.25B	2.28B	2.11B	2.40B	2.58B	7.6%
Non-Operating Items
Interest Income	9.00M	16.00M	49.00M	163.00M	38.00M	-76.7%
Interest Expense	(469.00M)	(398.00M)	(452.00M)	(528.00M)	(613.00M)	16.1%
Other Income/Expenses (Net)	-558.00M	-499.00M	-449.00M	-392.00M	-696.00M	77.6%
Income Before Tax	1.69B	1.78B	1.66B	2.00B	1.88B	-6.1%
Income Tax Expense	(88.00M)	(148.00M)	(132.00M)	(300.00M)	(204.00M)	-32.0%
Net Income	2.09B	1.78B	1.48B	1.71B	1.68B	-1.6%
Per Share Metrics
Earnings Per Share (Basic)	$7	$6	$5	$6	$6	-0.7%
Weighted Avg Shares Outstanding	289.29M	285.00M	286.28M	289.76M	286.61M	-1.1%
Weighted Avg Shares Outstanding (Diluted)	292.09M	287.36M	288.39M	291.01M	287.12M	-1.3%
EBITDA	4.39B	4.41B	4.40B	4.82B	4.96B	2.9%

Explore BDX

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

BDX in the Healthcare

Large Cap

Healthcare

Browse sector stocks →

Medical - Instruments & Supplies

Browse industry stocks →